These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 36278505)
1. Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy. Sanders CB; Knisely K; Rathfoot C; Edrissi C; Nathaniel T Clin Appl Thromb Hemost; 2022; 28():10760296221116347. PubMed ID: 36278505 [No Abstract] [Full Text] [Related]
2. Risk Factors Associated With Exclusion of Obese Patients Ischemic Stroke With a History of Smoking From Thrombolysis Therapy. Brewer PC; Ojo DT; Broughton PX; Imeh-Nathaniel A; Imeh-Nathaniel S; Nathaniel TI Clin Appl Thromb Hemost; 2024; 30():10760296241246264. PubMed ID: 38600881 [TBL] [Abstract][Full Text] [Related]
3. Risk factors and ambulatory outcome in ischemic stroke patients with pre-stroke depression. Okon M; Blum B; Nathaniel TI J Vasc Nurs; 2021 Dec; 39(4):91-99. PubMed ID: 34865727 [TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of comorbidities in stroke patients with a history of obstructive sleep apnea treated with thrombolytic therapy. Knisely K; Sanders CB; Edrissi C; Rathfoot C; Poupore N; Bailey-Taylor MJ; Stewart B; Nathaniel T J Vasc Nurs; 2022 Jun; 40(2):74-85. PubMed ID: 35750378 [TBL] [Abstract][Full Text] [Related]
5. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy. Inohara T; Liang L; Kosinski AS; Smith EE; Schwamm LH; Hernandez AF; Bhatt DL; Fonarow GC; Peterson ED; Xian Y J Am Heart Assoc; 2019 Aug; 8(15):e012450. PubMed ID: 31327296 [TBL] [Abstract][Full Text] [Related]
6. Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients. Poupore N; Strat D; Mackey T; Brown K; Snell A; Nathaniel TI Lipids Health Dis; 2020 May; 19(1):84. PubMed ID: 32375780 [TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke. Moraney R; Poupore N; Shugart R; Tate M; Snell A; Brown K; Nathaniel TI J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104890. PubMed ID: 32807408 [TBL] [Abstract][Full Text] [Related]
9. Acute stroke management in the elderly. Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089 [TBL] [Abstract][Full Text] [Related]
10. Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients. Brecthel L; Gainey J; Penwell A; Nathaniel TI BMC Neurol; 2018 Dec; 18(1):215. PubMed ID: 30577762 [TBL] [Abstract][Full Text] [Related]
11. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR; Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191 [TBL] [Abstract][Full Text] [Related]
12. Gender and thrombolysis therapy in acute ischemic stroke patients with incidence of obesity. Blum B; Penwell A; Wormack L; Walker B; Lari S; Nathaniel TI Neurol Sci; 2019 Sep; 40(9):1829-1839. PubMed ID: 31049791 [TBL] [Abstract][Full Text] [Related]
13. Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia. Blum B; Wormack L; Holtel M; Penwell A; Lari S; Walker B; Nathaniel TI BMC Womens Health; 2019 Jan; 19(1):11. PubMed ID: 30651099 [TBL] [Abstract][Full Text] [Related]
14. Low-dose intravenous recombinant tissue plasminogen activator in acute ischemic stroke without large vessel occlusion screened by 3T MRI. Huynh QS; Tran CC; Nguyen-Thi HT; Nguyen TT; Phan-Thi HL; Luu-Dang DT; Le MT; Nguyen MD Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6554-6562. PubMed ID: 37522667 [TBL] [Abstract][Full Text] [Related]
15. Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid -19 and non-covid -19 patients. Khedr EM; Abdelwarith A; Moussa G; Saber M J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107031. PubMed ID: 36701854 [TBL] [Abstract][Full Text] [Related]
16. Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: a prospective cohort study. Li L; Han Z; Wang R; Fan J; Zheng Y; Huang Y; Yang Z; Yan F; Liu P; Zhao H; Ma Q; Luo Y J Neuroinflammation; 2023 Mar; 20(1):70. PubMed ID: 36906528 [TBL] [Abstract][Full Text] [Related]
17. In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy? Rotimi OR; Ajani IF; Penwell A; Lari S; Walker B; Nathaniel TI Womens Health (Lond); 2020; 16():1745506520922760. PubMed ID: 32459136 [TBL] [Abstract][Full Text] [Related]
18. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia. Mowla A; Kamal H; Lail NS; Vaughn C; Shirani P; Mehla S; Rajabzadeh-Oghaz H; Deline C; Ching M; Crumlish A; Sawyer RN J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1414-1418. PubMed ID: 28438515 [TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Adeoye O; Hornung R; Khatri P; Kleindorfer D Stroke; 2011 Jul; 42(7):1952-5. PubMed ID: 21636813 [TBL] [Abstract][Full Text] [Related]
20. Impact of thrombolysis in acute ischaemic stroke without occlusion: an observational comparative study. Ajili N; Decroix JP; Preda C; Labreuche J; Lopez D; Bejot Y; Michel P; Sévin-Allouet M; Sibon I; Vergnet S; Wang A; Sanda N; Mazighi M; Bourdain F; Lapergue B Eur J Neurol; 2016 Aug; 23(8):1380-6. PubMed ID: 27222165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]